Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC.
paper
Cited
Public
- Authors
- Hasin, Deborah; Kilcoyne, Bari
- Year
- 2012
- Journal
- Current opinion in psychiatry
- PMID
- 22449770
- DOI
- 10.1097/YCO.0b013e3283523dcc
- PMCID
- PMC3767413
PURPOSE OF REVIEW: The comorbidity between psychiatric and substance use disorders remains an important phenomenon to understand, and an active area of investigation. The purpose of this review is to highlight key 2011 issues and novel findings on psychiatric and substance disorders comorbidity from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a large national survey of the US general population. RECENT FINDINGS: Topics of active investigation included the internalizing/externalizing meta-structure of common mental disorders; the 10 Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) personality disorders; the 3-year incidence and persistence of disorders; treatment of major depression; and many other topics not as easily categorized. SUMMARY: Meta-structure may increasingly offer a parsimonious way of addressing comorbidity, although adding new disorders adds complexity and the value of etiologic analyses utilizing broad dimensions of psychopathology rather than individual disorders is not yet fully known. Expanding the range of personality disorders beyond antisocial personality disorder appears essential in understanding the incidence and persistence of substance use disorders. Substance use disorders have low rates of treatment relative to major depression, but increase the likelihood of depression treatment among comorbid cases, a phenomenon that needs to be understood. These comorbidity studies provide much novel information, and indicate many potentially fruitful directions for new research.
No figures extracted from this document.
1β20 of 24
Next β
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Chronic Pain and Substance Use Disorders: A Brief Narrative Review of Genetic, Neurobiological, and Environmental Contributions to Comorbidity. | Villela PNR et al. | β | 2025 | β |
| Clinical Needs of Older Adults With Personality Disorders: Insights From State-Funded Mental Health Care Systems. | Edwards ER et al. | β | 2025 | β |
| Exploring the Role of Racial Microaggressions in the Association Between Depression Symptoms and Drug Use and Related Harm Among Women of Color Experiencing Intimate Partner Violence. | Thomas ED et al. | β | 2025 | β |
| Maternal perinatal depression and the risk of disruptive behavioural disorder symptoms among offspring: A systematic review and meta-analysis. | Tusa BS et al. | β | 2025 | β |
| Maternal pre- and perinatal depression and the risk of autism spectrum disorders in offspring: systematic review and meta-analysis. | Tusa BS et al. | β | 2025 | β |
| Psychopathy is a neglected public health problem. | Chinchilla MA et al. | β | 2025 | β |
| Substance-induced mental disorders and discontinuation of medication for opioid use disorder. | Tilhou AS et al. | β | 2025 | β |
| A Descriptive Review and Meta-Regression Study of Demographic and Study Context Factors in US Clinical Trials of Cognitive Behavioral Interventions for Alcohol or Other Drug Use. | Burnett DP et al. | β | 2024 | β |
| Discovery and validation of genes driving drug-intake and related behavioral traits in mice. | Roy TA et al. | β | 2024 | β |
| Female Patients Show a Larger Reduction in Suicidal Ideation in Inpatient Addiction Treatment Than Male Patients: Results of a Single-Center Observational Study. | Grote V et al. | β | 2024 | β |
| Increased white blood cellΒ in young adults with family histories of alcohol and other substance use disorders. | Mithaiwala MN et al. | β | 2024 | β |
| Age- and Sex-Varying Associations Between Depressive Symptoms and Substance Use from Modal Ages 35 to 55 in a National Sample of U.S. Adults. | Patrick ME et al. | β | 2023 | β |
| Co-occurrence of food addiction, obesity, problematic substance use, and parental history of problematic alcohol use. | Hoover LV et al. | β | 2023 | β |
| Correlates of Homelessness Among Adults with Personality Disorder. | Dell NA et al. | β | 2023 | β |
| Cue-reactivity targeted smoking cessation intervention in individuals with tobacco use disorder: a scoping review. | Luo M et al. | β | 2023 | β |
| Normative Modelling of Molecular-based Functional Neurocircuits Captures Clinical Heterogeneity Transdiagnostically in Neuropsychiatric Patients | Lawn T et al. | β | 2023 | β |
| Pain Intensity Moderates the Association between Obsessive-Compulsive Symptoms and Problematic Alcohol Use among Emerging Adults. | Bakhshaie J et al. | β | 2023 | β |
| The Association Between Depression and Substance Use Among Primary Care Patients With Comorbid Medical and Behavioral Health Conditions. | McGovern MP et al. | β | 2023 | β |
| The validity of transdiagnostic factors in predicting homotypic and heterotypic continuity of psychopathology symptoms over time. | Jung B et al. | β | 2023 | β |
| Molecular genetics of cocaine use disorders in humans. | FernΓ ndez-Castillo N et al. | β | 2022 | β |
| Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway. | Scarth M et al. | β | 2022 | β |
| A Systematic Review and Meta-Analysis of the Risk of Disruptive Behavioral Disorders in the Offspring of Parents with Severe Psychiatric Disorders. | Ayano G et al. | β | 2021 | β |
| Atypical interoception as a common risk factor for psychopathology: A review. | Brewer R et al. | β | 2021 | β |
| Depression and substance use disorders: Clinical comorbidity and shared neurobiology. | Calarco CA et al. | β | 2021 | β |
| Efficacy of the Unified Protocol for the treatment of comorbid alcohol use and anxiety disorders: Study protocol and methods. | Farchione TJ et al. | β | 2021 | β |
| Transdiagnostic dimensions of psychopathology explain individuals' unique deviations from normative neurodevelopment in brain structure. | Parkes L et al. | β | 2021 | β |
| Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit. | Daigre C et al. | β | 2021 | β |
| Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder. | Kotzalidis GD et al. | β | 2021 | β |
| Alcohol, Tobacco, and Comorbid Psychiatric Disorders and Associations With Sexual Identity and Stress-Related Correlates. | Evans-Polce RJ et al. | β | 2020 | β |
| An update on the role of common genetic variation underlying substance use disorders. | Johnson EC et al. | β | 2020 | β |
| Identifying Psychological Pathways to Polyvictimization: Evidence from a Longitudinal Cohort Study of Twins from the United Kingdom. | Tanksley PT et al. | β | 2020 | β |
| The General Factor of Psychopathology. | Smith GT et al. | β | 2020 | β |
| Becoming an Evidence-Based Practitioner. | Lowis MM et al. | β | 2019 | β |
| Genome-wide association meta-analysis of cocaine dependence: Shared genetics with comorbid conditions. | Cabana-DomΓnguez J et al. | β | 2019 | β |
| Multi-, Inter-, and Transgenerational Effects of Drugs of Abuse on Behavior. | Vassoler FM et al. | β | 2019 | β |
| Testing Cold and Hot Cognitive Control as Moderators of a Network of Comorbid Psychopathology Symptoms in Adolescence. | Madole JW et al. | β | 2019 | β |
| The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063). | Tsuyuki K et al. | β | 2019 | β |
| Adult attachment representations and depressive symptoms: A meta-analysis. | Dagan O et al. | β | 2018 | β |
| Comorbid mental disorders among adults in the mental health surveillance survey. | Forman-Hoffman VL et al. | β | 2018 | β |
| Effects of the Personalized Recovery Oriented Services (PROS) Program on Hospitalizations. | White C et al. | β | 2018 | β |
| Personality Disorder and Alcohol Use Disorder: An Overview. | Newton-Howes G et al. | β | 2018 | β |
| The cross-national structure of mental disorders: results from the World Mental Health Surveys. | de Jonge P et al. | β | 2018 | β |
| The role of trauma in the hormonal interplay of cortisol, testosterone, and oxytocin in adolescent aggression. | Fragkaki I et al. | β | 2018 | β |
| Inhalant Use and Mental Health Problems in Russian Juvenile Delinquents. | Zachrison L et al. | β | 2017 | β |
| Integrated Dual Disorder Treatment Implementation in a Large State Sample. | Harrison J et al. | β | 2017 | β |
| Stereotype threat and social function in opioid substitution therapy patients. | von Hippel C et al. | β | 2017 | β |
| Substance use disorders in adolescent and young adult relatives of probands with bipolar disorder: What drives the increased risk? | Hulvershorn LA et al. | β | 2017 | β |
| The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain. | Daigre C et al. | β | 2017 | β |
| Transdiagnostic Extension of Delusions: Schizophrenia and Beyond. | Bebbington P et al. | β | 2017 | β |
| Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement. | Carey CE et al. | β | 2016 | β |
| Factors associated with high use of general practitioner and psychiatrist services among patients attending an addiction rehabilitation center. | Huα»³nh C et al. | β | 2016 | β |
| Individuals developing schizophrenia are hidden among adolescent substance misusers. | Hodgins S et al. | β | 2016 | β |
| Medication-assisted treatment for substance use disorders within a national community health center research network. | Rieckmann T et al. | β | 2016 | β |
| Prolonged length of stay in ED psychiatric patients: a multivariable predictive model. | Warren MB et al. | β | 2016 | β |
| Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment. | Rolland B et al. | β | 2016 | β |
| Social, familial and psychological risk factors for mood and anxiety disorders in childhood and early adulthood: a birth cohort study using the Danish Registry System. | Hyland P et al. | β | 2016 | β |
| Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. | Suzuki J et al. | β | 2016 | β |
| A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients. | Icick R et al. | β | 2015 | β |
| Age-varying associations between substance use behaviors and depressive symptoms during adolescence and young adulthood. | Schuler MS et al. | β | 2015 | β |
| Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment. | Schellekens AF et al. | β | 2015 | β |
| Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems. | Sanchez K et al. | β | 2015 | β |
| Impact of Exposure to Childhood Maltreatment on Transitions to Alcohol Dependence in Women and Men. | Oberleitner LM et al. | β | 2015 | β |
| Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). | Kronenberg LM et al. | β | 2015 | β |
| The Challenge Behind the Facade: Substance Abuse and Comorbidities. | UluΔ BD | β | 2015 | β |
| ADHD and the externalizing spectrum: direct comparison of categorical, continuous, and hybrid models of liability in a nationally representative sample. | Carragher N et al. | β | 2014 | β |
| Biological substrates of addiction. | Joffe ME et al. | β | 2014 | β |
| Cultural Influences on Substance Use Among Hispanic Adolescents and Young Adults: Findings From Project RED. | Unger JB | β | 2014 | β |
| Diagnostic challenges in alcohol use disorder and alcoholic liver disease. | Vonghia L et al. | β | 2014 | β |
| Engagement in assertive community treatment as experienced by recovering clients with severe mental illness and concurrent substance use. | Pettersen H et al. | β | 2014 | β |
| Individual differences in risk-related behaviors and voluntary alcohol intake in outbred Wistar rats. | Momeni S et al. | β | 2014 | β |
| Personality disorders and the persistence of substance use disorders: A reanalysis of published NESARC findings. | VergΓ©s A et al. | β | 2014 | β |
| Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism. | Reilly MT et al. | β | 2014 | β |
| Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder. | Glass JE et al. | β | 2014 | β |
| Shared clinical associations between obesity and impulsivity in rapid cycling bipolar disorder: a systematic review. | Galvez JF et al. | β | 2014 | β |
| Substance-abusing mothers and fathers' willingness to allow their children to receive mental health treatment. | Kelley ML et al. | β | 2014 | β |
| The p Factor: One General Psychopathology Factor in the Structure of Psychiatric Disorders? | Caspi A et al. | β | 2014 | β |
| Alcohol stigma and persistence of alcohol and other psychiatric disorders: a modified labeling theory approach. | Glass JE et al. | β | 2013 | β |
| Conduct disorder and initiation of substance use: a prospective longitudinal study. | Hopfer C et al. | β | 2013 | β |
| Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trial. | McCollister KE et al. | β | 2013 | β |
| Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs. | Connor JP et al. | β | 2013 | β |